Osaic Holdings’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8K | Buy |
137
+4
| +3% | +$140 | ﹤0.01% | 6160 |
|
|
2025
Q1 | $1.13K | Sell |
133
-4
| -3% | -$34 | ﹤0.01% | 6634 |
|
|
2024
Q4 | $4.91K | Hold |
137
| – | – | ﹤0.01% | 6103 |
|
|
2024
Q3 | $6.49K | Sell |
137
-2
| -1% | -$95 | ﹤0.01% | 5985 |
|
|
2024
Q2 | $6.99K | Sell |
139
-12
| -8% | -$603 | ﹤0.01% | 5915 |
|
|
2024
Q1 | $16.9K | Sell |
151
-2
| -1% | -$224 | ﹤0.01% | 5422 |
|
|
2023
Q4 | $8.89K | Sell |
153
-4
| -3% | -$232 | ﹤0.01% | 5849 |
|
|
2023
Q3 | $4.98K | Buy |
157
+28
| +22% | +$888 | ﹤0.01% | 6206 |
|
|
2023
Q2 | $10.6K | Hold |
129
| – | – | ﹤0.01% | 5890 |
|
|
2023
Q1 | $13.3K | Hold |
129
| – | – | ﹤0.01% | 5784 |
|
|
2022
Q4 | $19K | Hold |
129
| – | – | ﹤0.01% | 5587 |
|
|
2022
Q3 | $22K | Hold |
129
| – | – | ﹤0.01% | 5501 |
|
|
2022
Q2 | $15K | Buy |
129
+4
| +3% | +$465 | ﹤0.01% | 5795 |
|
|
2022
Q1 | $12K | Buy |
125
+90
| +257% | +$8.64K | ﹤0.01% | 5995 |
|
|
2021
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 6539 |
|
|
2021
Q3 | $8K | Buy |
35
+2
| +6% | +$457 | ﹤0.01% | 6313 |
|
|
2021
Q2 | $11K | Buy |
33
+22
| +200% | +$7.33K | ﹤0.01% | 5982 |
|
|
2021
Q1 | $5K | Buy |
11
+9
| +450% | +$4.09K | ﹤0.01% | 6108 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 6137 |
|
|
2020
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 5953 |
|
|
2020
Q2 | $1K | Sell |
2
-16
| -89% | -$8K | ﹤0.01% | 5861 |
|
|
2020
Q1 | $3K | Buy |
+18
| New | +$3K | ﹤0.01% | 5471 |
|